BPC-157 (Oral)
BPC-157 Capsules / Oral BPC
Oral BPC-157 is BPC-157 taken by mouth, as capsules or liquid. Rat studies reported effects when it was given by mouth as well as by injection, but no human study has measured whether it is absorbed or works orally. It is not FDA-approved, and most practitioner protocols use SubQ injection instead.
Half-life
Not established in humans
Typical Dose
No established oral dose
Route
oral
Category
healing
Evidence Overview
Strength of evidence across clinical, expert, and experimental lanes.
How BPC-157 (Oral) is dosed in practice
Usually taken by mouth. Typical range: No established oral dose. Half-life: Not established in humans. Each card gives the dose, frequency and duration from one evidence lane: Clinical (human trials), Expert (practitioner protocols) or Experimental (early or animal data). These ranges describe what has been studied or used; they are not a prescription.
Work out the units to draw with the reconstitution calculator, how long a vial lasts with the vial duration calculator, and how levels fall between doses with the half-life calculator.
BPC-157 was first described as a fragment of a protein found in gastric juice, and rat studies reported effects with oral as well as injected dosing. No human pharmacokinetic or outcome study of oral BPC-157 has been published, so whether meaningful amounts are absorbed in people is unknown. Most practitioner protocols use SubQ injection, where the dosing conventions on the BPC-157 page apply.
- Animal studies (oral and injected dosing)
- No human studies of oral use
Unlock Full Evidence Sources
Get complete clinical data, expert protocols, and experimental research for BPC-157 (Oral) and 90+ other compounds with Pro.
Upgrade to ProSafety & Contraindications
- Active cancer or history of cancer (may promote angiogenesis)
- Pregnancy or breastfeeding
- Known hypersensitivity to peptide compounds
BPC-157 (Oral): common questions
What is BPC-157 (Oral)?
Oral BPC-157 is BPC-157 taken by mouth, as capsules or liquid. Rat studies reported effects when it was given by mouth as well as by injection, but no human study has measured whether it is absorbed or works orally. It is not FDA-approved, and most practitioner protocols use SubQ injection instead.
How is BPC-157 (Oral) dosed?
BPC-157 (Oral) is usually taken by mouth. Typical range in DoseCraft's library: No established oral dose. Experimental (early or animal data): No established oral dose; Not established; Not established. These ranges describe what has been studied or used; they are not a prescription.
Is BPC-157 (Oral) FDA-approved?
No. BPC-157 (Oral) is not approved by the FDA for any use in people.
What is the half-life of BPC-157 (Oral)?
DoseCraft's library lists a half-life of Not established in humans. Half-life sets how often a compound is dosed and how long it takes to clear: about five half-lives.
Who should not use BPC-157 (Oral)?
Listed contraindications: Active cancer or history of cancer (may promote angiogenesis); Pregnancy or breastfeeding; Known hypersensitivity to peptide compounds.
Free Guides for BPC-157 (Oral)
Information is for educational purposes only. Always consult a licensed healthcare provider before starting any peptide regimen.
Page updated . How we grade evidence: methodology.